Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

BDSX
Biodesix, Inc. Common Stock
stock NASDAQ

At Close
May 16, 2025 3:59:30 PM EDT
0.3257USD+48.045%(+0.1057)45,896,218
0.00Bid   0.00Ask   0.0000Spread
Pre-market
May 16, 2025 9:28:30 AM EDT
0.2130USD-3.182%(-0.0070)33,318
After-hours
May 16, 2025 4:58:30 PM EDT
0.3507USD+7.676%(+0.0250)13,924,028
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 19, 2022
09:19AM EST  PierianDx And Biodesix Partner To Advance Lung Cancer Diagnostics   Benzinga
Jan 18, 2022
06:07AM EST  Biodesix Announces Launch Of GeneStrat NGS Test And The IQLung Testing Strategy   Benzinga
Jan 5, 2022
08:20AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets   Benzinga
Jan 4, 2022
05:11PM EST  Biodesix Shares Spike Higher; Director Jack Schuler Buys 2,298,850 Shares At Average Price Of $4.35/Share   Benzinga
04:04PM EST  Biodesix Reports Sale Of ~3.76M Common Shares In At-The-Market Offering, Will Raise ~$16.3M   Benzinga
Dec 22, 2021
04:19PM EST  Biodesix Filing Shows Registration For $50M Common Stock Shelf Offer   Benzinga
Dec 7, 2021
03:38PM EST  Biodesix US Patent & Trademark Office Abstract Shows Co. Granted Patent For Its 'Compositions, methods and kits for diagnosis of lung cancer'   Benzinga
Dec 1, 2021
06:07AM EST  Biodesix Partners With Spesana To Streamline Digital Access To Molecular Diagnostics For Precision Medicine In Lung Cancer   Benzinga
Nov 24, 2021
03:44PM EST  Biodesix European Patent Office Specification For Co.'s 'BLOOD SAMPLE SEPARATION DEVICES AND METHODS'   Benzinga
Nov 23, 2021
12:49PM EST  Biodesix Shares Move Higher; Co Reports In Form4 Filing Director Jack Schuler Buys 60K Shares At Average Price Of $6.50/Share   Benzinga
Nov 17, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021   Benzinga
07:58AM EST  Morgan Stanley Downgrades Biodesix to Equal-Weight, Lowers Price Target to $11   Benzinga
Nov 15, 2021
11:07AM EST  Earnings Scheduled For November 15, 2021   Benzinga
11:03AM EST  Biodesix Q3 EPS $(0.41) Beats $(0.48) Estimate, Sales $6.50M Beat $6.17M Estimate   Benzinga
Oct 19, 2021
09:38AM EDT  Biodesix Granted U.S. Patent Titled 'Method for identification of cancer patients with durable benefit from immunotherapy in overall poor prognosis subgroups'   Benzinga
Oct 13, 2021
06:05AM EDT  Biodesix Highlights Announcement Of Data On Nodify Lung Nodule Risk Assessment Testing at CHEST 2021 Annual Meeting   Benzinga
Sep 22, 2021
12:54PM EDT  Biodesix's Return On Capital Employed Insights   Benzinga
Sep 16, 2021
09:22AM EDT  Biodesix Highlights Presentation Of Abstracts At IASLC 2021 World Conference On Lung Cancer   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 10, 2021
04:08PM EDT  Biodesix Q2 EPS $(0.41) Misses $(0.29) Estimate, Sales $11.88M Up From $4.24M YoY   Benzinga
04:05AM EDT  Earnings Scheduled For August 10, 2021   Benzinga
Aug 2, 2021
06:00AM EDT  Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference   Business Wire
Jul 29, 2021
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
Jul 28, 2021
07:33AM EDT  The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal   Benzinga
Jul 23, 2021
07:45AM EDT  The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs   Benzinga
Jul 21, 2021
07:52AM EDT  The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay   Benzinga
Jul 8, 2021
07:45AM EDT  The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test   Benzinga
Jun 21, 2021
09:40AM EDT  Looking Into Biodesix's Return On Capital Employed   Benzinga
Jun 17, 2021
04:02PM EDT  Biodesix, Seer Highlight Presentation Of Webinar 'A New Era in Precision Medicine - Uncovering the Depth & Breadth of the Plasma Proteome with Novel Proteomic Technologies'   Benzinga
Jun 15, 2021
08:07AM EDT  The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda   Benzinga
06:02AM EDT  Biodesix Announces Commercial Availability Of SARS CoV-2 Neutralization Antibody Test   Benzinga
Jun 4, 2021
09:00AM EDT  Biodesix Partners with Datavant to Enhance Value of Lung Cancer   GlobeNewswire Inc
06:02AM EDT  Biodesix Reports Partnership With Datavant To Enhance Value Of Lung Cancer Databank, No Terms Disclosed   Benzinga
Jun 3, 2021
11:09AM EDT  Biodesix: Return On Capital Employed Insights   Benzinga
May 26, 2021
07:01AM EDT  First Patient Enrolled In Biodesix And Addario Lung Cancer Medical Institute Study Aiming To Predict Patient Survival UsingA Blood-Based Biomarker   Benzinga
07:01AM EDT  First Patient Enrolled in Biodesix and Addario Lung Cancer Medical Institute   PR Newswire
May 12, 2021
07:37AM EDT  Morgan Stanley Maintains Overweight on Biodesix, Lowers Price Target to $23   Benzinga
May 11, 2021
04:04PM EDT  Biodesix Q1 EPS $(0.26) Misses $(0.17) Estimate, Sales $28.87M Beat $26.25M Estimate   Benzinga
12:47PM EDT  Earnings Scheduled For May 11, 2021   Benzinga
Apr 28, 2021
06:09AM EDT  Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Results Possible in 72 Hours   Benzinga
Apr 26, 2021
04:03PM EDT  Biodesix Ro Present On SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Commercial Launch Plans May 5   Benzinga
Apr 12, 2021
09:53AM EDT  Biodesix Saturday Morning Announced New Data On Proteomic Profiling Presented Atk American Association For Cancer Research Apr. 10   Benzinga
Apr 6, 2021
08:05AM EDT  The Daily Biotech Pulse: Illumina Lights Up, Cara Soars On Index Inclusion, Novavax Starts Crossover Vaccine Study, Turning Point Data Readout   Benzinga
06:16AM EDT  Biodesix Announces Issuance of Two US Patents   Benzinga
Mar 23, 2021
04:01PM EDT  Biodesix Announces Closing of New $30M Term Loan   Benzinga
04:00PM EDT  Biodesix Announces Closing of New $30 Million Term Loan   Business Wire
Mar 18, 2021
07:54AM EDT  Morgan Stanley Maintains Overweight on Biodesix, Raises Price Target to $25   Benzinga
Mar 17, 2021
01:36PM EDT  Biodesix on Tuesday Reported Q4 EPS $(0.25) Beats $(0.44) Estimate, Sales $27.03M Beat $15.45M Estimate   Benzinga
Mar 16, 2021
04:46AM EDT  Earnings Scheduled For March 16, 2021   Benzinga
Feb 16, 2021
06:36AM EST  Biodesix Collaborates With Chicago Public Schools For COVID-19 Testing To Safely Reopen Schools   RTTNews
06:31AM EST  Biodesix To Provide Antigen And Droplet Digital PCR Testing For Chicago Public School Teachers And Staff   Benzinga
06:30AM EST  Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools   Business Wire
Feb 12, 2021
06:30AM EST  Biodesix to Participate in Two February Conferences   Business Wire
Feb 9, 2021
06:35AM EST  Biodesix Published Data on New COVID-19 Artificial Intelligence (AI)-Based Algorithm for Use in Clinical Decision Support Systems; New Data Show Ai-based Algorithm Rapidly Predicts Risk of Severe Outcomes for Patients Hospitalized for Covid-19 Infection   Benzinga
06:30AM EST  Biodesix Publishes Data on New COVID-19 Artificial Intelligence (AI)-Based Algorithm for Use in Clinical Decision Support Systems   Business Wire
Feb 2, 2021
11:49AM EST  Canaccord Genuity Maintains Buy on Biodesix, Raises Price Target to $31   Benzinga
07:30AM EST  Scott Hutton of Biodesix Selected as USA Chief Executive Officer of the Year by CEO Monthly Magazine   Business Wire
Jan 26, 2021
06:30AM EST  Biodesix to Showcase New Data on Patient Immune Profiling from Multiple Studies at World Lung Conference   Business Wire
Jan 21, 2021
08:05AM EST  The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping   Benzinga
Jan 20, 2021
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
Jan 15, 2021
07:57AM EST  The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges   Benzinga
Jan 14, 2021
07:57AM EST  The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates   Benzinga
Jan 13, 2021
07:11AM EST  HiberCell, Biodesix Initiate Broad Collaboration For Companion Diagnostic Discovery, Development And Commercialization   RTTNews
07:08AM EST  HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization; Terms Of The Partnership Were Not Disclosed   Benzinga
07:01AM EST  HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic   PR Newswire
07:00AM EST  HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization   Business Wire
Jan 12, 2021
08:16AM EST  The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue   Benzinga
Jan 8, 2021
06:04AM EST  Biodesix Sees Prelim. Q4 Sales $25M-$27M vs $15.55M Est.   Benzinga
Dec 23, 2020
06:03AM EST  Biodesix Reports Initiation OF Biomarker Study To Affirm Nodify XL2 Test's Importance In Clinical Decision Making   Benzinga
Dec 10, 2020
05:26PM EST  Biodesix Q3 EPS $(31.93) Up From $(39.25) YoY, Sales $9.19M Up From $3.94M YoY   Benzinga
Nov 23, 2020
11:01AM EST  William Blair Initiates Coverage On Biodesix with Outperform Rating   Benzinga
07:47AM EST  BTIG Initiates Coverage On Biodesix with Buy Rating, Announces Price Target of $22   Benzinga
07:47AM EST  Morgan Stanley Initiates Coverage On Biodesix with Overweight Rating, Announces Price Target of $20   Benzinga
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
Nov 18, 2020
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 9, 2020
05:01PM EST  Lawrence T. Kennedy, Jr. Reveals New 12.9% Passive Stake In Biodesix   Benzinga
Oct 30, 2020
04:15PM EDT  Biodesix Announces Closing of Initial Public Offering   Business Wire
08:09AM EDT  The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts   Benzinga
Oct 29, 2020
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 28, 2020
12:42PM EDT  Biodesix Shares Open At $13.59; IPO Priced At $18/Share   Benzinga
08:56AM EDT  Biodesix Shares Will Open For Quote At 10:35 a.m. EDT, Expected To Open For Trade After 10:45 a.m. EDT, IPO Priced At $18.00/Share   Benzinga
08:54AM EDT  IPOs Happening Today, Wednesday, Oct. 28, 2020: AJAX.U, ACICU, BDSX, BOAC.U, GATO, MAX, ROOT   Benzinga
06:48AM EDT  A Peek Into The Markets: US Stock Futures Tumble; GE, Ford Earnings In Focus   Benzinga
05:18AM EDT  Biodesix Priced 4M Share IPO @$18/Share   Benzinga
Oct 25, 2020
02:29PM EDT  IPO Outlook: Insurance Cos., Mortgage Providers, Leslie's Pool Supplies Highlight This Week's Offerings   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC